Uji Aktivitas Senyawa Aktif Daun Sirsak (Annona Muricata L.) sebagai Kandidat Antidepresan dengan Pendekatan In silico

Sutan Mulia Ananda, Gemah Nuripah, Lelly Yuniarti

Abstract


ABSTRACT: Depression is a mental disorder characterized by the effects of depression, loss of interest, and decreased energy. Treatment of depression uses antidepressant drugs that work to normalize the neurotransmitters serotonin, norepinephrine, and dopamine. Based on the mechanism, antidepressant drugs are classified into Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonine-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine Oxidase Inhibitors (MAOIs), and Tricyclic Antidepressants (TCAs). Apart from conventional medicines, depression can be treated with herbal remedies such as soursop (Annona muricata L.) leaves. The purpose of this study was to determine the effectiveness and mechanism of the active compound of soursop leaves (Annona muricata L.) as an antidepressant drug using the in silico approach. In this study, the in silico method was carried out with the help of computer devices and online data bases such as PubChem, SwissTargetPrediction, and STRING to analyze the target protein. This research was conducted in March-December 2020. The results showed 13 active compounds of soursop leaves (Annona muricata L.) can bind to eight target proteins, namely ACHE (acetylcholinesterase), ADRA2C (Alpha-2C adrenergic receptor), DRD1 (D1A dopamine receptor), DRD2 (D2 dopamine receptor), HTR2A (5-hydroxytryptamine receptor 2A), HTR2C (5-hydroxytryptamine receptor 2C), MAOA (Monoamine oxidase A) and SLC6A3 (Sodium-dependent dopamine transporter). The conclusion of this study that the active compounds contained in soursop leaves (Annona muricata L.) can affect the receptors and metabolic processes of dopamine, norepinephrine, and serotonine.

Keywords: Annona muricata L., Antidepressants, In silico, Soursop Leaves.

ABSTRAK: Depresi merupakan gangguan jiwa yang ditandai dengan afek depresi, kehilangan minat, dan penurunan energi. Pengobatan depresi menggunakan obat-obatan antidepresan yang bekerja untuk menormalkan neurotransmiter serotonin, norepinefrin, dan dopamin. Berdasar atas mekanismenya, obat antidepresan digolongkan menjadi Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonine-Norepinephrine Reuptake Inhibitor (SNRIs), Monoamine Oxidase Inhibitors (MAOIs), dan Tricyclic Antidepressants (TCAs). Selain dengan obat-obatan konvensional, depresi dapat diobati dengan pengobatan herbal seperti daun sirsak (Annona muricata L.). Tujuan penelitian ini adalah untuk mengetahui efektivitas dan mekanisme senyawa aktif daun sirsak (Annona muricata L.) sebagai obat antidepresan dengan pendekatan in silico. Pada penelitian ini, metode in silico dilakukan dengan bantuan perangkat komputer dan data base online seperti PubChem, SwissTargetPrediction, dan STRING untuk menganalisis protein target. Penelitian ini dilakukan pada bulan Maret−Desember 2020. Hasil penelitian menunjukkan 13 senyawa aktif daun sirsak (Annona muricata L.) dapat berikatan dengan delapan protein target yaitu ACHE (acetylcholinesterase), ADRA2C (Alpha-2C adrenergic receptor), DRD1 (D1A dopamine receptor), DRD2 (D2 dopamine receptor), HTR2A (5-hydroxytryptamine receptor 2A), HTR2C (5-hydroxytryptamine receptor 2C), MAOA (Monoamine oxidase A) dan SLC6A3 (Sodium-dependent dopamine transporter). Kesimpulan penelitian ini senyawa aktif yang terkandung dalam daun sirsak (Annona muricata L.) dapat memengaruhi reseptor dan proses metabolisme dopamin, norepinefrin dan serotonin.

Kata Kunci: Annona muricata L., Antidepresan, Daun Sirsak, In silico.


Keywords


Annona muricata L., Antidepresan, Daun Sirsak, In silico.

References


Marcus M, Yasamy MT, van Ommeren M, Chisholm D. Depression, a global public health concern.World Federation for Mental Health. 2012;6–8.

World Health Organization. Depression and other common mental disorders. Global Health Estimates. 2017;5–20.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington DC. 2013. 133–137.

Wulandari A, Purnomowati A, Wahmurti T. Deteksi disfungsi endotel pada gangguan depresi mayor dengan pengukuran endothelial-dependent flow-mediated vasodilatation. Glob Med Heal Commun. 2017;5(1):27–32.

Oakley C, Malik A. Rapid psychiatry. 2nd ed. West Sussex: Wiley-Blackwell; 2010. 49–50.

Bertram G. Katzung. Basic and clinical pharmacology. 14th ed. San Fransisco: McGraw-Hil; 2017. 310–330.

Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences/clinical psychiatry. 11th ed. Vol. 4. New York: Wolters Kluwer; 2015. 347–356.

Bjornlund L. Depression (diseases & disorders). 1st ed. Depression. New York: Lucent Books; 2010. 9–88.

Ningtyas RA, Puspitasari MI, Sinuraya KA. Review artikel : farmakoterapi depresi dan pengaruh jenis kelamin terhadap efikasi antidepresan. Farmaka. 2016;16(2):186–201.

David DJ, Gourion D. Antidepressant and tolerance: determinants and management of major side effects. Encephale. 2016;42(6):553–61.

Rajput M, Sinha S, Mathur V, Agrawal P. Herbal antidepressants. Int J Pharm Front Res. 2011;1(1):159–69.

Liu L, Liu C, Wang Y, Wang P, Li Y, Li B. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol. 2015;13(4):481–93.

Khurshid MHA. Drug discovery and in silico techniques: a mini-review. Enzym Eng. 2014;04(01):1–3.

Timotius KH. Pengantar metodologi penelitian: pendekatan manajemen pengetahuan untuk perkembangan pengetahuan. Yogyakarta. Penerbit Andi; 2017. 14–5.

Puspitasari DE, Amin M, Lukiati B. Analisis protein target senyawa alami anti aging flavan-3-ol dari Theobroma cacao L. Pros Semin Nas Pendidik dan Saintek. 2016;1:108–13.

Lannuzel A, Michel PP, Caparros-Lefebvre D, Abaul J, Hocquemiller R, Ruberg M. Toxicity of annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe. Mov Disord. 2002;17(1):84–90.

Li HT, Wu HM, Chen HL, Liu CM, Chen CY. The pharmacological activities of (-)-anonaine. Molecules. 2013;18(7):8257–63.

Martínez-Vázquez M, Estrada-Reyes R, Araujo Escalona AG, Ledesma Velázquez I, Martínez-Mota L, Moreno J, et al. Antidepressant-like effects of an alkaloid extract of the aerial parts of Annona cherimolia in mice. J Ethnopharmacol. 2012;139(1):164–70.

Perviz S, Khan H, Pervaiz A. Plant alkaloids as an emerging therapeutic alternative for the treatment of depression. Front Pharmacol. 2016;7(28):1–7.

Bhattacharya SK, Bose R, Ghosh P, Tripathi VJ, Kay AB, Dasgupta B. Psychopharmacological studies on (-)-nuciferine and its hofmann degradation product atherosperminine. Psychopharmacology (Berl). 1978;59(1):29–33.

Grosso C. Herbal medicine in depression: traditional medicine to innovative drug delivery. Herbal Medicine in Depression: Traditional Medicine to Innovative Drug Delivery. 2016. 1–585 p.

Hawkins KM, Smolke CD. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat Chem Biol. 2008;4(9):564–73.

Sirvent A, García-Muñoz MJ, Yus M, Foubelo F. Stereoselective synthesis of tetrahydroisoquinolines from chiral 4-azaocta-1,7-diynes and 4-azaocta-1,7-enynes. European J Org Chem. 2020;2020(1):113–26.

Munusamy V, Yap BK, Buckle MJC, Doughty SW, Chung LY. Structure-based identification of aporphines with selective 5-HT2A receptor-binding activity. Chem Biol Drug Des. 2013;81(2):250–6.

Heng HL, Chee CF, Thy CK, Tee JT, Chin SP, Herr DR, et al. In vitro functional evaluation of isolaureline, dicentrine and glaucine enantiomers at 5-HT2 and α1 receptors. Chem Biol Drug Des. 2019;93(2):132–8.

Siddique YH, Naz F, Jyoti S, Ali F, Rahul. Effect of genistein on the transgenic drosophila model of parkinson’s disease. J Diet Suppl. 2019;16(5):550–63.

Dhiman P, Malik N, Sobarzo-Sánchez E, Uriarte E, Khatkar A. Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: targeting neurological and mental disorders. Molecules. 2019;24(3):1-18.

Ademosun AO, Oboh G, Bello F, Ayeni PO. Antioxidative properties and effect of quercetin and its glycosylated form (rutin) on acetylcholinesterase and butyrylcholinesterase activities. J Evidence-Based Complement Altern Med. 2016;21(4):NP11–7.

Lee BH, Choi SH, Kim HJ, Jung SW, Hwang SH, Pyo MK, et al. Differential effects of quercetin and quercetin glycosides on human α7 nicotinic acetylcholine receptor-mediated ion currents. Biomol Ther. 2016;24(4):410–7.

Upadhyay MR, Patel AB, Subramanian RB, Shah TM, Jakhesara SJ, Bhatt VD, et al. Single nucleotide variant detection in jaffrabadi buffalo (Bubalus bubalis) using high-throughput targeted sequencing. Front Life Sci. 2015;8(2):192–9.




DOI: http://dx.doi.org/10.29313/kedokteran.v7i1.26873

Flag Counter